These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 25010110)

  • 1. Antibodies to Toxoplasma gondii and cognitive functioning in schizophrenia, bipolar disorder, and nonpsychiatric controls.
    Dickerson F; Stallings C; Origoni A; Katsafanas E; Schweinfurth L; Savage C; Khushalani S; Yolken R
    J Nerv Ment Dis; 2014 Aug; 202(8):589-93. PubMed ID: 25010110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibodies to Toxoplasma gondii in individuals with mania.
    Dickerson F; Stallings C; Origoni A; Vaughan C; Katsafanas E; Khushalani S; Yolken R
    Bipolar Disord; 2014 Mar; 16(2):129-36. PubMed ID: 24102676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum antibodies to Toxoplasma gondii and Herpesvidae family viruses in individuals with schizophrenia and bipolar disorder: a case-control study.
    Tedla Y; Shibre T; Ali O; Tadele G; Woldeamanuel Y; Asrat D; Aseffa A; Mihret W; Abebe M; Alem A; Medhin G; Habte A
    Ethiop Med J; 2011 Jul; 49(3):211-20. PubMed ID: 21991754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of cognitive deficits with elevated homocysteine levels in euthymic bipolar patients and its impact on psychosocial functioning: preliminary results.
    Dittmann S; Seemüller F; Schwarz MJ; Kleindienst N; Stampfer R; Zach J; Born C; Bernhard B; Fast K; Grunze H; Engel RR; Severus E
    Bipolar Disord; 2007; 9(1-2):63-70. PubMed ID: 17391351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognitive functioning in schizophrenia and bipolar disorder: comparison of performance on the Repeatable Battery for the Assessment of Neuropsychological Status.
    Dickerson F; Boronow JJ; Stallings C; Origoni AE; Cole SK; Yolken RH
    Psychiatry Res; 2004 Nov; 129(1):45-53. PubMed ID: 15572184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurocognitive functioning as intermediary phenotype and predictor of psychosocial functioning across the psychosis continuum: studies in schizophrenia and bipolar disorder.
    Jabben N; Arts B; van Os J; Krabbendam L
    J Clin Psychiatry; 2010 Jun; 71(6):764-74. PubMed ID: 20122370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognitive functioning in recent onset psychosis.
    Dickerson F; Stallings C; Vaughan C; Origoni A; Khushalani S; Dickinson D; Medoff D
    J Nerv Ment Dis; 2011 Jun; 199(6):367-71. PubMed ID: 21629013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Infection with herpes simplex virus type 1 is associated with cognitive deficits in bipolar disorder.
    Dickerson FB; Boronow JJ; Stallings C; Origoni AE; Cole S; Krivogorsky B; Yolken RH
    Biol Psychiatry; 2004 Mar; 55(6):588-93. PubMed ID: 15013827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of Cumulative Herpesviridae and Toxoplasma gondii Infections on Cognitive Function in Healthy, Bipolar, and Schizophrenia Subjects.
    Hamdani N; Daban-Huard C; Godin O; Laouamri H; Jamain S; Attiba D; Delavest M; Lépine JP; Le Corvoisier P; Houenou J; Richard JR; Yolken RH; Krishnamoorthy R; Tamouza R; Leboyer M; Dickerson FB
    J Clin Psychiatry; 2017 Jan; 78(1):e18-e27. PubMed ID: 27929612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated C-reactive protein and cognitive deficits in individuals with bipolar disorder.
    Dickerson F; Stallings C; Origoni A; Vaughan C; Khushalani S; Yolken R
    J Affect Disord; 2013 Sep; 150(2):456-9. PubMed ID: 23684514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibodies to infectious agents in individuals with recent onset schizophrenia.
    Leweke FM; Gerth CW; Koethe D; Klosterkötter J; Ruslanova I; Krivogorsky B; Torrey EF; Yolken RH
    Eur Arch Psychiatry Clin Neurosci; 2004 Feb; 254(1):4-8. PubMed ID: 14991372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infection and inflammation in schizophrenia and bipolar disorder.
    Tanaka T; Matsuda T; Hayes LN; Yang S; Rodriguez K; Severance EG; Yolken RH; Sawa A; Eaton WW
    Neurosci Res; 2017 Feb; 115():59-63. PubMed ID: 27856235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Cytomegalovirus and Toxoplasma gondii Antibody Titers With Bipolar Disorder.
    Frye MA; Coombes BJ; McElroy SL; Jones-Brando L; Bond DJ; Veldic M; Romo-Nava F; Bobo WV; Singh B; Colby C; Skime MK; Biernacka JM; Yolken R
    JAMA Psychiatry; 2019 Dec; 76(12):1285-1293. PubMed ID: 31532468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maternal T. gondii, offspring bipolar disorder and neurocognition.
    Freedman D; Bao Y; Shen L; Schaefer CA; Brown AS
    Psychiatry Res; 2016 Sep; 243():382-9. PubMed ID: 27449007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The association among smoking, HSV-1 exposure, and cognitive functioning in schizophrenia, bipolar disorder, and non-psychiatric controls.
    Dickerson F; Adamos MB; Katsafanas E; Khushalani S; Origoni A; Savage CLG; Schroeder J; Schweinfurth LAB; Stallings C; Sweeney K; Yolken R
    Schizophr Res; 2016 Oct; 176(2-3):566-571. PubMed ID: 27262384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toxoplasma gondii in individuals with schizophrenia: association with clinical and demographic factors and with mortality.
    Dickerson F; Boronow J; Stallings C; Origoni A; Yolken R
    Schizophr Bull; 2007 May; 33(3):737-40. PubMed ID: 17314085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toxoplasma gondii infection and schizophrenia: a case control study in a low Toxoplasma seroprevalence Mexican population.
    Alvarado-Esquivel C; Urbina-Álvarez JD; Estrada-Martínez S; Torres-Castorena A; Molotla-de-León G; Liesenfeld O; Dubey JP
    Parasitol Int; 2011 Jun; 60(2):151-5. PubMed ID: 21292026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quality of life in bipolar type I disorder and schizophrenia in remission: clinical and neurocognitive correlates.
    Brissos S; Dias VV; Carita AI; Martinez-Arán A
    Psychiatry Res; 2008 Jul; 160(1):55-62. PubMed ID: 18485488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sex differences in neuropsychological performance and social functioning in schizophrenia and bipolar disorder.
    Vaskinn A; Sundet K; Simonsen C; Hellvin T; Melle I; Andreassen OA
    Neuropsychology; 2011 Jul; 25(4):499-510. PubMed ID: 21463042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment with anti-toxoplasmic activity (TATA) for toxoplasma positive patients with bipolar disorders or schizophrenia: a cross-sectional study.
    Fond G; Boyer L; Gaman A; Laouamri H; Attiba D; Richard JR; Delavest M; Houenou J; Le Corvoisier P; Charron D; Krishnamoorthy R; Oliveira J; Tamouza R; Yolken R; Dickerson F; Leboyer M; Hamdani N
    J Psychiatr Res; 2015 Apr; 63():58-64. PubMed ID: 25769398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.